Antiangiogenic nanotherapy with lipase-labile Sn-2 fumagillin prodrug.
Pan D, Sanyal N, Schmieder AH, Senpan A, Kim B, Yang X, Hu G, Allen JS, Gross RW, Wickline SA, Lanza GM.
Pan D, et al. Among authors: senpan a.
Nanomedicine (Lond). 2012 Oct;7(10):1507-19. doi: 10.2217/nnm.12.27. Epub 2012 Jun 18.
Nanomedicine (Lond). 2012.
PMID: 22709347
Free PMC article.